Jason Wang  


Executive Summary

Jason Wang is an associate in our Securities and Capital Markets Group in our Calgary office. Jason's practice is focused on securities and corporate law, with an emphasis on corporate finance, mergers and acquisitions, information technology, cannabis, energy, and start-up companies. Jason speaks conversational Mandarin. 

Jason's practice is focused on assisting clients on a broad range of securities and corporate matters, including mergers, acquisitions and dispositions of both private and public companies; financing transactions including public and private offerings of debt and equity securities; and compliance with both corporate and securities regulatory requirements relating to stock exchange listings, corporate governance, continuous disclosure obligations, and shareholders' meetings.

Jason is a member of the BLG Cannabis Industry Focus Group representing a variety of industry participants in relation to the Controlled Drugs and Substances Act and its regulations, including the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"), including licensed producers, licensed producer applicants, licensed dealers, research and development labs, e-commerce platforms, and design and build firms. Jason's understanding of the ACMPR and other applicable law, his close attention to the Cannabis Act and Alberta's Bill 26: An Act to Control and Regulate Cannabis, and his familiarity with the Canadian cannabis industry and its participants, each add value when advising domestic and foreign clients.

Representative Work

  • Acted for the agents in connection with the brokered private placement financing of a TSX Venture Exchange issuer.
  • Acted for Maple Leaf Green World Inc. (TSXV: MGW) in its $7.2 million non-brokered private placement.
  • Acts for investment fund managers in connection with the creation of pooled mutual funds and private equity funds.
  • Acted for veterinary clients in all manner of commercial law areas including the purchase of veterinary clinics, incorporation, and drafting agreements.
  • Acts for exempt market dealers in connection with registration with the securities commissions.
  • Acted for the purchaser in connection with the receivership and sale of a public oil and gas services company. 
  • Advises companies in governance and compliance with corporate and securities regulatory requirements.
  • Advising a natural health products company in relation to the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") and the Narcotic Control Regulations (the "NCR")
  • Advising multiple technology companies (domestic and foreign), including licensed producers, licensed dealers, and applicants, in relation to:
    • Cannabis supply agreements;
    • Scope of activities under ACMPR licences, NCR licences, and Marihuana Medical Access Regulations licences extended by R v Allard; and
    • Importation and exportation of cannabis under the ACMPR and the NCR.
  • Acts for issuers, underwriters and agents in connection with public and private equity and debenture financings.
  • Represents companies in mergers and acquisitions, including plans of arrangement, amalgamations, and share purchase transactions.
  • Assists clients in the reorganization and restructuring of corporations, partnerships, and other entities.
  • Advises companies in governance and compliance with corporate and securities regulatory requirements.
  • Acts as counsel to various capital pool companies in connection with incorporation, private financing, initial public offerings, stock exchange listings, and qualifying transactions.
  • Acting for start-up companies in various matters including incorporation, organization, reorganization, initial and subsequent private placements, and employee-related compensation matters.

Publications & Presentations